From: Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia
 | Tigecycline | Levofloxacin | ||||||
---|---|---|---|---|---|---|---|---|
Isolate | n | MIC Range | MIC50 | MIC90 | n | MIC Range | MIC50 | MIC90 |
Streptococcus pneumoniae (penicillin susceptible) | 45 | 0.030, 0.120 | 0.060 | 0.060 | 45 | 0.250, 2.000 | 1.000 | 1.000 |
Penicillin-intermediate S. pneumoniae | 8 | 0.060, 0.060 | NA | NA | 8 | 1.000, 1.000 | NA | NA |
Penicillin-resistant S. pneumoniae | 5 | 0.060, 0.060 | NA | NA | 5 | 1.000, 2.000 | NA | NA |
Haemophilus influenzae | 18 | 0.120, 0.500 | 0.250 | 0.500 | 18 | 0.120, 0.120 | 0.120 | 0.120 |
Haemophilus parainfluenzae | 13 | 0.250, 0.500 | 0.500 | 0.500 | 13 | 0.120, 0.120 | 0.120 | 0.120 |
Klebsiella pneumoniae | 11 | 0.250, 2.000 | 0.500 | 1.000 | 11 | 0.120, 0.500 | 0.120 | 0.120 |
Staphylococcus aureus (all non-MRSA) | 15 | 0.120, 0.250 | 0.120 | 0.120 | 15 | 0.120, 0.250 | 0.120 | 0.250 |